Tolerance to appetite suppression induced by peptidoglycan

Infection and Immunity

Volumn 64, Issue 9, 1996, Pages 3641-3645

  Biberstine, Karla J ^a   Darr, David S ^a   Rosenthal, Raoul S ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDOGLYCAN;

ANIMAL EXPERIMENT; ANOREXIA; ARTICLE; DOSE RESPONSE; EATING HABIT; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGICAL TOLERANCE; MALE; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; RAT;

EID: 0029756758     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.9.3641-3645.1996     Document Type: Article

References (32)

1. Berkenbosch, F. J. Van Oers, A. Del Rev, F. Tilder, and H. Besedovsky. 1987. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238:524-526.
2. Besedovsky, H., A. Del Rey, E. Sorkin, C. A. Dinarello, and C. B. Saper. 1986. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233:652-654.
3. Biberstine, K. J., and R. S. Rosenthal. 1994. Peptidoglycan fragments decrease food intake and body weight gain in rats. Infect. Immun. 62:3276-3281.
4. Cavaillon, J. M., and N. Haeffner-Cavaillon. 1990. Signals involved in interleukin-1 synthesis and release by lipopolysaccharide-stimulated monocytes/ macrophages. Cytokine 2:313-329.
5. Damais, C., G. Riveau, M. Parant, J. Gerota, and L. Chedid. 1982. Production of lymphocyte activating factor in the absence of endogenous pyrogen by rabbit or human leukocytes stimulated by a muramyldipeptide derivative. Int. J. Immunopharmacol. 4:451-462.
6. Dinarello, C. A. 1991. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of septic shock syndrome. J. Infect. Dis. 163:1177-1184.
7. Dinarello, C. A., R. J. Ellin, L. Chedid, and S. M. Wolff. 1978. The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues. J. Infect. Dis. 138:760-767.
8. Dinarello, C. A., and J. M. Krueger. 1986. Induction of interleukin-1 by synthetic and naturally occurring muramyl peptides. Fed. Proc. 45:2545-2548.
9. Dokter, W. H. A., A. J. Dijkstra, S. B. Koopmans, B. K. Stulp, W. Keck, M. R. Halie, and E. Vellenga. 1994. G(Anh)MTetra, a natural bacterial cell wall breakdown product, induces interleukin-1 beta and interleukin-6 expression in human monocytes. A study of the molecular mechanisms involved in inflammatory cytokine expression. J. Biol. Chem. 269:4201-4206.
10. Dripps, D. J., B. J. Brandhuber, R. C. Thompson, and S. P. Eisenberger. 1991. Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J. Biol. Chem. 266: 10331-10336.
11. Ellouz, F., R. Adam, R. Ciorbaru, and E. Lederer. 1974. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun. 59:1317-1325.
12. Fernandez-Botron, R. 1991. Soluble cytokine receptors: their role in immunoregulation. FASEB J. 5:2567-2574.
13. Greisman, S. E. 1983. Induction of endotoxin tolerance, p. 149-178. In A. Nowotny (ed.), Beneficial effects of endotoxin. Plenum Press, New York.
14. Hannum, C. H., C. J. Wilcox, W. P. Arend et al. 1990. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature (London) 343:336-340.
15. Hellerstein, M. K., S. M. Meydani, M. Meydani, K. Wu, and C. A. Dinarello. 1989. Interleukin-1-induced anorexia in the rat. J. Clin. Invest. 84:228-235.
16. Johannsen, L. 1993. Biological properties of peptidoglycan. APMIS 101: 337-344.
17. Kruger, J. M., J. R. Pappenheimer, and M. L. Karnovsky. 1982. Sleep promoting effects of muramyl peptides. Proc. Natl. Acad. Sci. USA 79:6102-6106.
18. Langhans, W., R. Harlacher, G. Balkowski, and E. Scharrer. 1990. Comparison of the effects of bacterial lipopolysaccharide and muramyl dipeptide on food intake. Physiol. Behav. 47:805-813.
19. McCarthy, D. O., M. J. Kluger, and A. J. Vander. 1984. The role of fever in appetite suppression after endotoxin administration. Am. J. Clin. Nutr. 40: 310-316.
20. Mengozzi, M., and P. Ghezzi. 1991. Defective tolerance to the toxic and metabolic effects of interleukin-1. Endocrinology 128:1668-1672.
21. Mrosovsky, N., L. A. Molony, C. A. Conn, and M. J. Kluger. 1989. Anorexic effects of interleukin-1 in the rat. Am. J. Physiol. 257:R1315-R1321.
22. 2 and bacterial lipopolysaccharide stimulate bioactive interleukin-1 release from rat hypothalamic explants. Neuroendocrinol. 57:257-261.
23. Nguyen-Hey, H., C. Nauciel, and C. G. Wermuth. 1976. Immunochemical study of the peptidoglycan of Gram-negative bacteria. Eur. J. Biochem. 66: 79-84.
24. Otterness, I. G., H. W. Golden, W. H. Brissette, P. A. Seymour, and G. O. Daumy. 1989. Effects of continuously administered murine interleukin-1 alpha: tolerance development and granuloma formation. Infect. Immun. 57: 2742-2750.
25. Rahman, M. U., S. Ahmed, H. R. Schumacher, and A. R. Zeiger. 1990. High levels of peptidoglycan antibodies in psoriatic and other seronegative arthritides. J. Rheumatol. 17:621-625.
26. Riveau, G., K. Masek, M. Parant, and L. Chedid. 1980. Central pyrogenic activity of muramyl dipeptide. J. Exp. Med. 152:869-877.
27. Rivier, C., R. Chizzonite, and W. Vale. 1989. In the mouse, the activation of the hypothalamic-adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1. Endocrinology 125:2800-2805.
28. Sapolsky, R., C. Rivier, G. Yamamoto, P. Plotsky, and W. Vale. 1987. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238:522-524.
29. Socher, S. H., A. Friedman, and D. Martinez. 1988. Recombinant tumor necrosis factor reduces acute reductions in food intake and body weight in mice. J. Exp. Med. 167:1957-1962.
30. Soszynski, D., W. Kozak, and M. Szewczenko. 1991. Course of fever response to repeated administration of sublethal doses of lipopolysaccharides. Experientia 47:43-47.
31. Staber, F. G. 1980. Diminished response of granulocyte-macrophage colonys-timulating factor (GM-CSF) in mice after sensitization with bacterial cell-wall components. Exp. Hematol. 8:120-133.
32. Uehara, A., P. E. Gottschall, R. R. Dahl, and A. Arimura. 1987. Interleukin-1 stimulates ACTH release by an indirect action which requires endogenous corticotropin-releasing factor. Endocrinology 121:1580-1582.